Ownership and insider activity for NeurAxis, Inc. (NRXS): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics.
Price
| Price | $6.94 |
| Market Cap | $87M |
| Exchange | AMEX |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-08-24 | Carrico Thomas Joeseph | A-Award | 306,236 | |
| 2026-08-24 | Carrico Thomas Joeseph | A-Award | 193,678 | |
| 2026-08-24 | Carrico Thomas Joeseph | C-Conversion | 306,236 | |
| 2026-08-24 | Carrico Thomas Joeseph | C-Conversion | 306,236 | |
| 2026-08-24 | Miranda Adrian | A-Award | 337,204 | |
| 2026-08-24 | Miranda Adrian | A-Award | 199,106 | |
| 2026-08-24 | Miranda Adrian | C-Conversion | 337,204 | |
| 2026-08-24 | Miranda Adrian | C-Conversion | 337,204 | |
| 2026-08-24 | Carrico Brian Allen | A-Award | 320,000 | |
| 2026-08-24 | Carrico Brian Allen | A-Award | 199,188 |
Balance Sheet (10y)
| Year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.9M | $320858 | $253699 | $78560 | $3.7M | $5.0M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | $311329 | $115301 | $174399 | $73167 | $244618 | $195703 |
| Inventory | $106846 | $39180 | $48133 | $21220 | $44328 | $257132 |
| Total Current Assets | $2.5M | $491009 | $476957 | $242610 | $4.3M | $5.7M |
| Property, Plant & Equipment | $301705 | $245517 | $189393 | $158815 | $374638 | $337129 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $25897 | $23956 | $77558 | $108073 | $96588 | $274778 |
| Total Assets | $2.8M | $760482 | $1.5M | $509498 | $4.8M | $6.4M |
| Accounts Payable | $164558 | $483790 | $1.6M | $1.2M | $596946 | $139365 |
| Short-term Debt | $151005 | $250407 | $489227 | $148062 | $154152 | $148293 |
| Total Current Liabilities | $1.0M | $1.4M | $7.0M | $1.9M | $2.4M | $2.8M |
| Long-term Debt | 0 | $51692 | 0 | 0 | 0 | 0 |
| Total Liabilities | $1.1M | $1.6M | $7.1M | $1.9M | $2.7M | $3.0M |
| Retained Earnings | -$26.1M | -$29.2M | -$33.9M | -$48.6M | -$56.8M | -$64.6M |
| Total Equity | $1.6M | -$825660 | -$5.6M | -$1.4M | $2.1M | $3.4M |
| Total Debt | $311492 | $439275 | $598821 | $224260 | $473405 | $416611 |
| Net Debt | -$1.6M | $118417 | $345122 | $145700 | -$3.2M | -$4.5M |
| Working Capital | $1.5M | -$933847 | -$6.5M | -$1.6M | $1.8M | $2.9M |
Financial Health
| Debt / Equity | 0.04 |
| Current Ratio | 3.04 |
Profitability
| Return on Equity | -173.28% |
| Return on Invested Capital | -109.52% |
| Return on Assets | -78.73% |
| Gross Margin | 85.56% |
| Operating Margin | -144.51% |
| Net Margin | -148.04% |
Related companies: CLGN · CVKD · ENLV · KLTO · NERV · NRSN · RLYB
Explore sector: Healthcare · Biotechnology
More sections of NRXS: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks